Search

23 Feb 2024: Search site. Wellcome-MRC Cambridge Stem Cell Institute. Upcoming events. Wellcome-MRC Cambridge Stem Cell Institute. Events. 26Feb. CSCI PhD and Postdoc Seminar - Jaana Bagri & Ziqi Dong. Speaker: Jaana Bagri, PhD student, Huntly Group. Speaker:

23 Feb 2024: Gottgens Group photo. Plain English. Blood stem cells ensure the constant supply of new blood cells throughout a person’s lifetime. ... Can we identify new strategies to treat leukaemia by reversing the disturbed balance of gene activities?

23 Feb 2024: Search site. Wellcome-MRC Cambridge Stem Cell Institute. New study illuminates ES Cells. ... Submitted by M. Zappone on Thu, 17/11/2016 - 14:43. A collaboration between two EuropeanCommission projects, HEROIC and EuroSyStem, has cast new light on the

23 Feb 2024: Search site. Wellcome-MRC Cambridge Stem Cell Institute. Our people. Wellcome-MRC Cambridge Stem Cell Institute. People. The Cambridge Stem Cell Institute has 28 research groups with over 300 biological, clinical and physical scientists operating

23 Feb 2024: These "disease-in-a-dish" models are being used to understand the pathobiology of these conditions and to screen for new treatments. ... With these and other approaches we are trying to understand how blood vessels become diseased and trying to find new

23 Feb 2024: Search site. Wellcome-MRC Cambridge Stem Cell Institute. New Group Leader/Clinician Scientist opportunities.

23 Feb 2024: We focus particularly on malignancy and regenerative failure, in studies which are laying the foundation for new approaches to diagnosis and treatment. ... We exploit the potential of stem cells to model diseases in vitro and to generate new diagnostic

23 Feb 2024: Search site. Wellcome-MRC Cambridge Stem Cell Institute. New research from Sinha Lab recreates genetic heart disease in a dish. ... Dr Sanjay Sinha, a BHF Senior Research Fellow, who led the research said: "We now hope to use our newfound understanding

23 Feb 2024: Search site. Wellcome-MRC Cambridge Stem Cell Institute. New drug target discovered for acute myeloid leukaemia. ... To identify potential new ways to treat AML, the researchers used CRISPR-Cas9 gene-editing technology to screen cancer cells for

23 Feb 2024: Search site. Wellcome-MRC Cambridge Stem Cell Institute. Uncovering new therapeutic interventions for Multiple Sclerosis. ... These findings will now be taken forward in a new Phase 2 clinical trial in 50 people with relapsing MS.